Armira and Viessmann to acquire an 40% stake in Pharos Generics.

Armira, a holding group focused on direct investments, and Viessmann, an international manufacturer of heating, cooling and air conditioning technology, agreed to acquire an 40% stake in Pharos Generics, a pharmaceutical development company. Financial terms were not disclosed.